Results 181 to 190 of about 699,373 (191)

The Short-Term Efficacy of Biweekly Subconjunctival Bevacizumab in Diabetic Macular Edema

Current Eye Research, 2020
Volkan Yeter, Ozlem Eski Yucel, Hakki Birinci   +2 more
exaly  

Subconjunctival bevacizumab in the impending recurrent pterygia

International Ophthalmology, 2013
Sezin Akca Bayar, Fehmi Cem Küçükerdönmez   +1 more
exaly  

Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up

Clinical and Experimental Ophthalmology, 2014
Yonathan Garfias
exaly  

Intrastromal and subconjunctival injection of bevacizumab for the treatment of corneal neovascularisation in children

2018
Yeo, Damien, Moore, William
openaire   +1 more source

Subconjunctival Injection of Bevacizumab (Avastin) on Corneal Neovascularization in Different Rabbit Models of Corneal Angiogenesis

Investigative Ophthalmology and Visual Science, 2009
Wei-Li Chen, Fung-Rong Hu, Lu-Ping Chow
exaly  

Subconjunctival bevacizumab for corneal neovascularization

Graefe's Archive for Clinical and Experimental Ophthalmology, 2007
Yuksel Totan, Mesut Erdurmuş
exaly  

Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits

Investigative Ophthalmology and Visual Science, 2009
Kazuyuki Hirooka, Fumio Shiraga, Shinobu Fujii   +2 more
exaly  

Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse

Cutaneous and Ocular Toxicology, 2011
Olga E Makri, Constantine D. Georgakopoulos, Nikolaos Pharmakakis   +2 more
exaly  

Pterygia: Pathogenesis and the Role of Subconjunctival Bevacizumab in Treatment

Seminars in Ophthalmology, 2009
C Stephen Foster
exaly  

[Subconjunctival injection of bevacizumab for treatment of corneal neovascularization after perforating keratoplasty].

Klinische Monatsblatter fur Augenheilkunde, 2009
M M, Maier, A, Erben, R, Khoramnia, D, Zapp, C, Winkler von Mohrenfels, C, Lohmann   +5 more
openaire   +1 more source